Wading Biotechnology Co., Ltd. (1733) Reports Q4 2025 Financials: EPS at NT$1.63
NQ Score
53/100
N1 Content Completeness
4
AI Summary (NQ-processed)
Wading Biotechnology Co., Ltd. (stock code 1733) announced its financial results for the fourth quarter of 2025. The company reported basic earnings per share (EPS) of NT$1.63 for the quarter. Quarterly operating revenue reached NT$1.945 billion, with a net profit after tax of NT$163 million. Wading Biotechnology specializes in the biotechnology and medical industry.
AI analysis data is not yet available.
Frequently Asked Questions
- Q: What is Wading Biotechnology's stock code?
- A: Wading Biotechnology's stock code is 1733.
- Q: What were Wading Biotechnology's basic earnings per share (EPS) for Q4 2025?
- A: The basic EPS for Q4 2025 was NT$1.63.
- Q: What was Wading Biotechnology's operating revenue in Q4 2025?
- A: The operating revenue for Q4 2025 was NT$1.945 billion.
- Q: What was Wading Biotechnology's net profit after tax in Q4 2025?
- A: The net profit after tax for Q4 2025 was NT$163 million.